Cargando…

Efficacy of low-dose rivaroxaban in an 88-year-old female with pulmonary embolism: A case report

RATIONALE: Rivaroxaban has numerous advantages over traditional anticoagulation therapy. Fixed doses can be administered without requiring routine monitoring of coagulation, and anticoagulation efficacy is more predictable. Safety, including fewer drug interactions, and reduced bleeding, is also imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Huanyu, Wei, Qi, Wu, Haidi, Tang, Minglong, Yang, Shuo, Liu, Yang, Qin, Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531187/ https://www.ncbi.nlm.nih.gov/pubmed/31096518 http://dx.doi.org/10.1097/MD.0000000000015705

Ejemplares similares

Rivaroxaban treatment for young patients with pulmonary embolism (Review)
por: Wu, Haidi, et al.
Publicado: (2020)

Current status of rivaroxaban in elderly patients with pulmonary embolism (Review)
por: Song, Zi-Kai, et al.
Publicado: (2020)

Routine coagulation test abnormalities caused by rivaroxaban: A case report
por: Song, Zikai, et al.
Publicado: (2018)

Nephrotic syndrome with acute pulmonary embolism in young adults: Two case reports
por: Song, Zikai, et al.
Publicado: (2018)

Efficacy of rivaroxaban for pulmonary embolism
por: Jia, Juan, et al.
Publicado: (2019)

Association Between D-Dimer Level and In-Hospital Death of Pulmonary Embolism Patients
por: Song, Zi-Kai, et al.
Publicado: (2020)

Rivaroxaban for the Treatment of Pulmonary Embolism
por: Vanassche, Thomas, et al.
Publicado: (2013)

Successful treatment of amniotic fluid embolism complicated by disseminated intravascular coagulation with rivaroxaban: A case report
por: Wu, Hai-Di, et al.
Publicado: (2020)

Efficacy of rivaroxaban for the treatment of Chinese patients with acute pulmonary embolism: A retrospective study
por: Wang, Lei, et al.
Publicado: (2021)

Effect of Rivaroxaban on Fibrinolytic Therapy in Massive Pulmonary Embolism: Two Cases
por: Kim, Hye-Jin, et al.
Publicado: (2014)

The Use of Rivaroxaban for Unprovoked Pulmonary Embolism in the Setting of Antithrombin Deficiency
por: Gryn, Oscar J, et al.
Publicado: (2020)

Massive Spontaneous Haemothorax after Rivaroxaban Therapy for Acute Pulmonary Embolism
por: Yan, Denise Tan, et al.
Publicado: (2019)

Efficacy and Safety of Rivaroxaban versus Warfarin for the Treatment of Acute Pulmonary Embolism: A Real-World Study
por: Huang, Yan, et al.
Publicado: (2020)

Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism
por: Song, Yijun, et al.
Publicado: (2023)

Sequential Therapy of Nadroparin and Rivaroxaban in the Initial Treatment of Patients With Acute Pulmonary Embolism
por: Xiong, Wei, et al.
Publicado: (2022)

Rivaroxaban Monotherapy in Patients with Pulmonary Embolism: Off-Label vs. Labeled Therapy
por: Di Micco, Pierpaolo, et al.
Publicado: (2022)

Pulmonary embolism and deep vein thrombosis in eosinophilic granulomatosis with polyangiitis successfully treated with rivaroxaban
por: Naito, Tomoyuki, et al.
Publicado: (2018)

Late Pulmonary Embolism after COVID-19 Pneumonia despite Adequate Rivaroxaban Treatment
por: Di Tano, Giuseppe, et al.
Publicado: (2020)

Apixaban or Rivaroxaban Versus Warfarin for Treatment of Submassive Pulmonary Embolism After Catheter-Directed Thrombolysis
por: Groetzinger, Lara M., et al.
Publicado: (2018)

Considerations for routine coagulation monitoring with rivaroxaban: A case report and review of the literature
por: Wu, Hai-Di, et al.
Publicado: (2019)

Treatment of Pulmonary Embolism With Rivaroxaban: Outcomes by Simplified Pulmonary Embolism Severity Index Score from a Post Hoc Analysis of the EINSTEIN PE Study
por: Fermann, Gregory J, et al.
Publicado: (2015)

Accidental Rivaroxaban Overdose in a Patient with Pulmonary Embolism: Some Lessons for Managing New Oral Anticoagulants
por: Sajkov, Dimitar, et al.
Publicado: (2015)

Clinical and Economic Outcomes in Low-risk Pulmonary Embolism Patients Treated with Rivaroxaban versus Standard of Care
por: Peacock, W. Frank, et al.
Publicado: (2019)

Syncope as the initial presentation of pulmonary embolism in a young adult with testicular tumor: A case report and literature review
por: Song, Zikai, et al.
Publicado: (2018)

Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban
por: Liu, Xiao-Qin, et al.
Publicado: (2023)

Management of Submassive Bilateral Pulmonary Embolism in an Adolescent Female
por: Lim, Adeline Yi Ling, et al.
Publicado: (2021)

SUSTAINED VENTRICULAR TACHYCARDIA AS AN INITIAL PRESENTATION OF COVID-19 RELATED PULMONARY EMBOLISM DESPITE PREVIOUS RIVAROXABAN THERAPY
por: Mendoza, Juan Alan Fuentes, et al.
Publicado: (2022)

Right atrial myxoma presenting as a pulmonary embolism in a 32-year-old female
por: Pandey, Amitabh C, et al.
Publicado: (2019)

Initial rivaroxaban dosing in patients with atrial fibrillation
por: Ablefoni, Kaja, et al.
Publicado: (2019)

Rivaroxaban: Lack of efficacy: case report
Publicado: (2021)

Use of rivaroxaban in an elderly patient with intermediate-low early mortality risk due to pulmonary embolism: a case report
por: Menichetti, Maurizio, et al.
Publicado: (2015)

Management of acute pulmonary embolism with sequential hybrid therapy of surgical thrombectomy and rivaroxaban intensive therapy: a case report
por: Migita, Shohei, et al.
Publicado: (2023)

Rivaroxaban for the treatment of symptomatic deep-vein thrombosis and pulmonary embolism in Chinese patients: a subgroup analysis of the EINSTEIN DVT and PE studies
por: Wang, Yuqi, et al.
Publicado: (2013)

Pulmonary embolism: new treatments for an old problem
por: Ryan, John
Publicado: (2016)

Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolism
por: Stöhr, Robert, et al.
Publicado: (2022)

Syncope as the initial presentation of pulmonary embolism in two patients with hepatocellular carcinoma: Two case reports and literature review
por: Deng, Dayong, et al.
Publicado: (2021)

Safety and Efficacy of Cryoballoon Pulmonary Vein Isolation and Left Atrial Appendage Closure Combined Procedure and Half-Dose Rivaroxaban After Operation in Elderly Patients with Atrial Fibrillation
por: Zhang, Xiaogang, et al.
Publicado: (2023)

Low-dose rivaroxaban: can cardiovascular events be reduced?
por: De Luca, Leonardo
Publicado: (2023)

High-pitched tin-filtered CT pulmonary angiography in radiation dose reduction for pulmonary embolism investigations in young females
por: Rehan, Saad, et al.
Publicado: (2023)

Heparin/rivaroxaban: Lack of efficacy: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k69mq54gjdjsnrne1dpr2q0l1n